The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out moreCreate an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
Co-Chair
Professor Sagar Lonial is currently the Chief Medical Officer at the Winship Cancer Institute of Emory University, Atlanta, US. He is also a Professor and Chair of the Department of Hematology and Medical Oncology at the Emory University School of Medicine, Atlanta, US.
Professor Lonial is internationally recognized as a leading authority in multiple myeloma treatment and research, having recently received a Lifetime Achievement Award for Outstanding Contributions to Hematology-Oncology from the Indo-American Cancer Association. As a medical oncologist, he treats patients with multiple myeloma and is a leading member of the bone marrow transplantation and clinical trials team. He has recently spent time developing the B-cell malignancy program with respect to novel targeted agents in laboratory models as well as early clinical trials.
Professor Lonial obtained his medical degree from the University of Louisville School of Medicine, Louisville, US, which was followed by a residency at the Baylor College of Medicine, Houston, US, and a fellowship in hematology and oncology at the Emory University School of Medicine, Atlanta, US.
Filter by content: